Selenium in Treating Patients With Prostate Cancer

Completed · Phase 2 · Has a placebo group

Conditions studied: Prostate Cancer

In brief

RATIONALE: Selenium may prevent or slow the growth of prostate cancer. PURPOSE: This randomized phase II trial is studying how well selenium works in treating patients with prostate cancer.

Key facts

Study ID

NCT00752739

Run by

University of Arizona

People needed

220

Starts

2002-08-01

Expected to finish

2007-04-01

Last updated by the study team

2012-08-15

Who can join

Age: any, up to 85. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Arizona Cancer Center at University of Arizona Health Sciences Center — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.